3-Arylcoumarin inhibits vascular calcification by inhibiting the generation of AGEs and anti-oxidative stress
Objective This work aims to screen drugs for preventing and treating vascular calcification. Method: We screened a series of 3-arylcoumarins for the detection of vascular calcification-associated factors using human aortic vascular smooth muscle cells.Results We found that compounds 14 and 32 signif...
Saved in:
Main Authors: | YuFei Li (Author), Yinbo Pan (Author), Liying Wang (Author), Xiaojing Wang (Author), Haiping Chu (Author), Yan Li (Author), Jie Sun (Author), Yanling Mu (Author) |
---|---|
Format: | Book |
Published: |
Taylor & Francis Group,
2022-12-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Synthesis and biological evaluation of 3-arylcoumarin derivatives as potential anti-diabetic agents
by: Yuheng Hu, et al.
Published: (2019) -
Synthesis and biological evaluation of 3-arylcoumarins as potential anti-Alzheimer's disease agents
by: Jie Yang, et al.
Published: (2019) -
Efficacy and mechanism of Shenqi Compound in inhibiting diabetic vascular calcification
by: Chan Yang, et al.
Published: (2023) -
Intermedin Alleviates Vascular Calcification in CKD through Sirtuin 3-Mediated Inhibition of Mitochondrial Oxidative Stress
by: Shi-Meng Liu, et al.
Published: (2022) -
Natural source, bioactivity and synthesis of 3-Arylcoumarin derivatives
by: Qiang Zhang, et al.
Published: (2022)